FATE THERAPEUTICS INC — Director's Dealing 2016

May 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2016-05-11

Reporting Person: RASTETTER WILLIAM H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-11	Stock Option (right to buy)	$1.69	A	25000	Acquired	2026-05-10	Common Stock (25000)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 11, 2017 or (ii) the date of the 2017 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

F2: Not applicable.